User profiles for Thomas E. Cope

Thomas E Cope

Consultant Neurologist, University of Cambridge
Verified email at cam.ac.uk
Cited by 2901

[PDF][PDF] The brain basis for misophonia

…, JS Winston, MF Callaghan, M Allen, TE Cope… - Current Biology, 2017 - cell.com
Misophonia is an affective sound-processing disorder characterized by the experience of
strong negative emotions (anger and anxiety) in response to everyday sounds, such as those …

[HTML][HTML] Age at symptom onset and death and disease duration in genetic frontotemporal dementia: an international retrospective cohort study

…, J Levin, A Danek, JB Rowe, TE Cope… - The Lancet …, 2020 - thelancet.com
Background Frontotemporal dementia is a heterogenous neurodegenerative disorder, with
about a third of cases being genetic. Most of this genetic component is accounted for by …

18F-AV-1451 positron emission tomography in Alzheimer's disease and progressive supranuclear palsy

…, D Williamson, RJ Borchert, S Sami, TE Cope… - Brain, 2017 - academic.oup.com
The ability to assess the distribution and extent of tau pathology in Alzheimer’s disease and
progressive supranuclear palsy in vivo would help to develop biomarkers for these …

Tau burden and the functional connectome in Alzheimer's disease and progressive supranuclear palsy

TE Cope, T Rittman, RJ Borchert, PS Jones… - Brain, 2018 - academic.oup.com
Alzheimer’s disease and progressive supranuclear palsy (PSP) represent neurodegenerative
tauopathies with predominantly cortical versus subcortical disease burden. In Alzheimer’s …

[HTML][HTML] Evidence for causal top-down frontal contributions to predictive processes in speech perception

TE Cope, E Sohoglu, W Sedley, K Patterson… - Nature …, 2017 - nature.com
Perception relies on the integration of sensory information and prior expectations. Here we
show that selective neurodegeneration of human frontal speech regions results in delayed …

Neuroinflammation and protein aggregation co-localize across the frontotemporal dementia spectrum

WR Bevan-Jones, TE Cope, PS Jones, SS Kaalund… - Brain, 2020 - academic.oup.com
The clinical syndromes of frontotemporal dementia are clinically and neuropathologically
heterogeneous, but processes such as neuroinflammation may be common across the disease …

Microglial activation in the frontal cortex predicts cognitive decline in frontotemporal dementia

…, TE Cope, D Street, PS Jones, FH Hezemans, E Mak… - Brain, 2023 - academic.oup.com
Frontotemporal dementia is clinically and neuropathologically heterogeneous, but
neuroinflammation, atrophy and cognitive impairment occur in all of its principal syndromes. Across …

[18F] AV-1451 binding in vivo mirrors the expected distribution of TDP-43 pathology in the semantic variant of primary progressive aphasia

WR Bevan-Jones, TE Cope, PS Jones… - Journal of Neurology …, 2018 - jnnp.bmj.com
Introduction Semantic dementia, including the semantic variant of primary progressive
aphasia (svPPA), is strongly associated with TAR-DNA binding protein 43 (TDP-43) type C …

[HTML][HTML] The basal ganglia in perceptual timing: timing performance in Multiple System Atrophy and Huntington's disease

TE Cope, M Grube, B Singh, DJ Burn, TD Griffiths - Neuropsychologia, 2014 - Elsevier
The timing of perceptual events depends on an anatomically and functionally connected
network comprising basal ganglia, cerebellum, pre-frontal cortex and supplementary motor area…

Synaptic Loss in Frontotemporal Dementia Revealed by [11C]UCB‐J Positron Emission Tomography

M Malpetti, PS Jones, TE Cope, N Holland… - Annals of …, 2023 - Wiley Online Library
Objective Synaptic loss is an early feature of neurodegenerative disease models, and is
severe in post mortem clinical studies, including frontotemporal dementia. Positron emission …